Imaging‐based staging of hepatic fibrosis in patients with hepatitis b: A dynamic radiomics model based on gd‐eob‐dtpa‐enhanced mri

Abstract

Accurate grading of liver fibrosis can effectively assess the severity of liver disease and help doctors make an appropriate diagnosis. This study aimed to perform the automatic staging of hepatic fibrosis on patients with hepatitis B, who underwent gadolinium ethoxybenzyl diethylene-triamine pentaacetic acid (Gd‐EOB‐DTPA)‐enhanced magnetic resonance imaging with dynamic radiomics analysis. The proposed dynamic radiomics model combined imaging features from multi‐phase dynamic contrast‐enhanced (DCE) images and time‐domain information. Imaging features were extracted from the deep learning‐based segmented liver volume, and time‐domain features were further explored to analyze the variation in features during contrast enhancement. Model construction and evaluation were based on a 132‐case data set. The proposed model achieved remarkable performance in significant fibrosis (fibrosis stage S1 vs. S2–S4; accuracy (ACC) = 0.875, area under the curve (AUC) = 0.867), advanced fibrosis (S1–S2 vs. S3–S4; ACC = 0.825, AUC = 0.874), and cirrhosis (S1–S3 vs. S4; ACC = 0.850, AUC = 0.900) classifications in the test set. It was more dominant compared with the conventional single‐phase or multi‐phase DCE‐based radiomics models, normalized liver enhancement, and some serological indicators. Time‐domain features were found to play an important role in the classification models. The dynamic radiomics model can be applied for highly accurate automatic hepatic fibrosis staging.